Apotex Inc. president and CEO Jeremy Desai resigned from the generic drug giant Friday while facing a lawsuit alleging he and the company accepted trade secrets leaked from a competitor. The lawsuit from Teva Pharmaceutical Industries Ltd. accuses Barinder Sandhu, who worked as a senior director of regulatory affairs for Teva’s U.S.
Name: Jeremy Desai
Continent: North America
Announcement Date: January 25, 2018, 11:00pm
Resignation Date: January 25, 2018, 11:00pm